Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sistema reported for 2023 by RAS

4/4/24 AFKS

Nornickel completes share split

4/4/24 GMKN

Pyatyorochka will open 150 stores a year in the Far East

4/4/24 X5

Novaev Group increased its share in the winery Manor Golubitskoe

4/4/24 BELU

Novatek will focus its efforts on Murmansk LNG

4/4/24 NVTK

Delimobile reported for 2023 according by RAS

4/4/24 DELI

Ozone has launched a fresh direction

4/4/24 OZON

Severstal acquired A Group's sales network

4/4/24 CHMF

Board of Directors of KuibyshevAzot recommended that dividends be paid for 2023

4/4/24 KAZT

Tinkoff created its own NPF

4/4/24 T